Overview of systematic reviews and meta-analysis of risperidone on cardiovascular risk: analysis of Cochrane and non-Cochrane systematic reviews including 11,949 patients
The available evidence from systematic reviews is of low to very low certainty and indicates substantial uncertainty regarding the cardiovascular effects of risperidone. Higher-quality systematic reviews with improved reporting and methodology are required.
Authors
- Silvia Helena Soares Gianini
- David M. Garner (ORCID: https://orcid.org/0000-0002-8114-9055)
- Igor Soares Gianini
- Andrey Alves [UNIFESP] Porto
- Rodrigo D. Raimundo
- Derfel R M A Folegatti
- Vitor E Valenti
Institutions
- Oxford Brookes University (GB)
- Universidade de Marília (BR)
- Centro Universitário Una (BR)
- Universidade Estadual Paulista (Unesp) (BR)
Publication Details
- Journal
- International Journal of Psychiatry in Clinical Practice
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1080/13651501.2026.2637451
- Primary Topic
- Pharmacological Receptor Mechanisms and Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00